Analgesic Effect of Adding an Adductor Canal Block to a Femoral Triangle Block for Total Knee Replacement

Total Knee Replacements Clinical Trial

Official title:

A Randomised Controlled Trial Investigating the Addition of an Adductor Canal Block to a Femoral Triangle Block for Analgesia After Total Knee Replacement

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03461679
• Other study ID #: 2017/ 2809 CGH
• Status: Completed
• Phase: N/A
• Start date: February 22, 2018
• Est. completion date: March 31, 2020

Study information

• Verified date: October 2020
• Source: Changi General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of the study is to investigate whether the addition of an adductor canal block to a femoral triangle block will provide better analgesia for patients after total knee replacements.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: March 31, 2020
• Est. primary completion date: March 31, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 45 Years and older

Eligibility

Inclusion Criteria:

• Patients undergoing total knee arthroplasty under spinal anaesthesia

• 45y or older

• ASA 1-3

• BMI 18-35

Exclusion Criteria:

• Unable to consent

• Chronic opioid consumption

• Allergy to study medication

• Lower limb surgery preceding year

• Unable to complete baseline testing, pre-existing neurological deficit

• Contraindication to spinal anaesthesia

Related Conditions & MeSH terms

• Total Knee Replacements

Intervention

Procedure:
• Adductor canal block
Single shot block with 0.5% bupivacaine 10mls
• Femoral triangle block
Single shot block with 0.5% bupivacaine 10mls

Locations

Country	Name	City	State
Singapore	Changi General Hospital	Singapore

Sponsors (1)

Lead Sponsor	Collaborator
Changi General Hospital

Country where clinical trial is conducted

Singapore, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Opioid consumption	Morphine	24 hours
Primary	Opioid consumption	Morphine	48 hours
Secondary	Muscle strength	measured with dynanometer	24 hours
Secondary	Muscle strength	measured with dynanometer	48 hours
Secondary	Time to up and go test	Time to get up from chair, walk 3 meters and return to chair	24 hours
Secondary	Time to up and go test	Time to get up from chair, walk 3 meters and return to chair	48 hours
Secondary	30 Chair stand test	Number of times a patient can stand up from sitting position in 30 seconds	24 hours
Secondary	30 Chair stand test	Number of times a patient can stand up from sitting position in 30 seconds	48 hours